Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)

NCT01303874 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Inflammatory Arthritis

Interventions

DRUG: Etanercept (ETN)
DRUG: Placebo

Sponsor

University of Leeds